Entering text into the input field will update the search result below

Aptevo collects $750K payment from sale of hemophilia therapy

Jun. 29, 2020 9:51 AM ETAptevo Therapeutics Inc. (APVO) StockBy: Vandana Singh, SA News Editor
  • Aptevo Therapeutics (NASDAQ:APVO +4.6%) collects in full $0.75M placed into an escrow account for working capital adjustments.
  • This collection relates to the Company's sale of its Hemophilia B therapy, IXINITY, to Medexus Pharmaceuticals.
  • The transaction, completed in February 2020, included an upfront payment to Aptevo of $30M; additionally Aptevo is eligible to receive potential milestone payments of up to $11M from Medexus.
  • Also, for up to 15 years, Aptevo will receive deferred payments on future US and Canadian net sales of IXINITY at a low to mid-single digit percentage of net sales.

Recommended For You

More Trending News

About APVO Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
APVO--
Aptevo Therapeutics Inc.